U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Search AHRQ

For an exact phrase match, enclose search terms in double quotes.

Go to Advanced Search
Go to Basic Search

Results

Total Results: 103 records

Showing results for "considerations".

  1. Implementation Guide: Statin Use for the Primary Prevention of CVD in Adults: Clinician-Facing CDS Intervention (pdf file)

    cds.ahrq.gov/sites/default/files/cds/artifact/18/2024_CDS_Connect_IG_Statin_CVD_Clinician_Facing.pdf
    January 01, 2024 - WG members provided guidance on translation of the recommendation statement, raised considerations to … with an LDL-C level greater than 190 mg/dL … these populations are at very high risk for CVD, and considerations … mg/dL or known familial hypercholesterolemia; these populations are at very high risk for CVD, and considerations … WG members provided guidance on translation of the recommendation statement, raised considerations to

  2. Implementation Guide: Statin Use for the Primary Prevention of CVD in Adults: Clinician-Facing CDS Intervention (pdf file)

    cds.ahrq.gov/sites/default/files/cds/artifact/18/2023_CDS_Connect_IG_Statin_CVD_Clinician_Facing.pdf
    January 01, 2023 - WG members provided guidance on translation of the recommendation statement, raised considerations to … adults with a LDL-C level greater than 190 mg/dL … these populations are at very high risk for CVD, and considerations … with … or known familial hypercholesterolemia; these populations are at very high risk for CVD, and considerations … WG members provided guidance on translation of the recommendation statement, raised considerations to

  3. Implementation Guide: Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication (pdf file)

    cds.ahrq.gov/sites/default/files/cds/artifact/26/2024_CDS_Connect_IG_Aspirin_Therapy.pdf
    January 01, 2024 - Considerations for future lab value specifications include (1) international normalize ratio (INR) >

  4. Implementation Guide: Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication (pdf file)

    cds.ahrq.gov/sites/default/files/cds/artifact/26/2023_CDS_Connect_IG_Aspirin_Therapy.pdf
    January 01, 2023 - Considerations for future lab value specifications include (1) international normalize ratio (INR) >

  5. CDS Connect Work Group October 2021 Summary (pdf file)

    cds.ahrq.gov/sites/default/files/workgroups/34806/CDS_Connect_WG_October_2021_Summary.pdf
    January 01, 2021 - CDS Connect Work Group October 2021 Summary Clinical Decision Support (CDS) Connect Work Group (WG) Meeting Summary October 21, 2021 3:00-4:00 pm ET Attendees: 39 people, including 3 phone dial-ins Organization Attendees AHRQ Sponsors Steve Bernstein, Edwin Lomotan, Mario Teran, James Swiger (4) WG…

  6. CDS Artifact Enhancement Based on Pilot Implementation. Factors to Consider in Managing Chronic Pain: (pdf file)

    cds.ahrq.gov/sites/default/files/cds/artifact/476/EnhancementofCDSArtifact%20BasedonPilotImplementation10012018.pdf
    December 01, 2018 - POPULATE Pain Management Summary Risk Considerations … laxative o Orders (date, active, completed, or stopped) o Statements (date, active, or completed) Risk Considerations

  7. CDS Connect Pilot Final Report (doc file)

    cds.ahrq.gov/sites/default/files/cds/artifact/18/Pilot%20Report_Final_0.docx
    March 01, 2018 - collaboration with the project’s clinical partner to ensure a balance of development rigor and real-world considerations … underlying differences between the USPSTF and ACC/AHA recommendation statements, and any potential workflow considerations

  8. CDS Connect - Maintenance and Update Final Report (Year 6) (pdf file)

    cds.ahrq.gov/sites/default/files/AHRQ_Final_Report_2022.pdf
    January 01, 2022 - CDS Connect - Maintenance and Update Final Report (Year 6) CDS Connect Maintenance and Update FINAL REPORT (Year 6 of CDS Connect) Agency for Healthcare Research and Quality 5600 Fishers Lane Rockville, MD 20857 www.ahrq.gov Contract No. 75FCMC18D0047 Prepared by: CMS Alliance to Modernize Healthcare …

  9. CDS Connect Maintenance and Update Final Report (Year 5 of CDS Connect) (pdf file)

    cds.ahrq.gov/sites/default/files/AHRQ_Final_Report_2021.pdf
    January 01, 2021 - Key considerations include being ever mindful of the end user of the CDS and creating transparency

  10. CDS Connect Implementation Guide Draft (doc file)

    cds.ahrq.gov/sites/default/files/cds/artifact/21/Implementation%20Guide_Statin%20Therapy%20for%20the%20Prevention%20and%20Treatment%20of%20CVD%20eCQM_Final.docx
    October 01, 2017 - . · Review the “clinical considerations” section of this document (including the decision log in Appendix … evaluates as true for Population 2, display the following notification: Evaluate comorbidities, safety considerations

  11. CDS Connect Final Report Year 2 (pdf file)

    cds.ahrq.gov/sites/default/files/reports/AHRQ_Final_Report_2018.pdf
    January 01, 2018 - laxative Orders (date, active, completed, or stopped) Statements (date, active, or completed) Risk Considerations … sections: Pertinent Medical History, Pain Assessments, Historical Pain-related Treatments, and Risk Considerations

  12. AHRQ CEDAR Final Project Report (pdf file)

    cds.ahrq.gov/cedar/AHRQ_CEDAR_Final_Project_Report_09_29_2022.pdf
    January 01, 2022 - AHRQ CEDAR Final Project Report AHRQ CEDAR Final Project Report Agency for Healthcare Research and Quality 5600 Fishers Lane Rockville, MD 20857 www.ahrq.gov Contract No. 75FCMC18D0047 Prepared by: CMS Alliance to Modernize Healthcare (The Health FFRDC) A Federally Funded Research and Development Cen…

  13. USPSTF Aspirin Therapy for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer (pdf file)

    cds.ahrq.gov/sites/default/files/cds/artifact/26/Implementation%20Guide_Aspirin%20Therapy%20for%20the%20Prevention%20of%20CVD%20and%20CRC_final.pdf
    January 01, 2020 - Considerations for future lab value specifications include (1) international normalize ratio (INR) >

  14. CDS Connect Maintenance and Update Final Report Year 4 2020 (pdf file)

    cds.ahrq.gov/sites/default/files/AHRQ_Final_Report_2020.pdf
    January 01, 2020 - CDS Connect Maintenance and Update Final Report Year 4 2020 CDS Connect CDS Connect Maintenance and Update Final Report (Year 4 of CDS Connect) Final Report (Year 4 of CDS Connect) CDS Connect Maintenance and Update Agency for Healthcare Research and Quality 5600 Fishers Lane Rockville, MD 20857 …

  15. CMS's Million Hearts Model Longitudinal ASCVD Risk Assessment Tool for Baseline 10-Year ASCVD Risk (pdf file)

    cds.ahrq.gov/sites/default/files/cds/artifact/71/Implementation_Guide_CMS_Million_Hearts_ASCVD_Risk_Assessment.pdf
    September 01, 2021 - The additional considerations for unattended bulk operation noted above also apply to this use case … • Review the “clinical considerations” section of this document (including the cited decision log

  16. CMS's Million Hearts Model Longitudinal ASCVD Risk Assessment Tool for Baseline 10-Year ASCVD Risk (pdf file)

    cds.ahrq.gov/sites/default/files/cds/artifact/71/Implementation%20Guide_CMS%20Million%20Hearts_ASCVD%20Risk%20Assessment_Level3_Final.pdf
    February 01, 2018 - The additional considerations for unattended bulk operation noted above also apply to this use case. … • Review the “clinical considerations” section of this document (including the cited decision log

  17. An Environmental Scan to Inform the Development of CEDAR (2023) (pdf file)

    cds.ahrq.gov/cedar/AHRQ_CEDAR_Environmental_Scan_2023_508.pdf
    January 01, 2023 - Available Repositories of Health-Related Data Repository Name Free / Open Access Description Considerations

  18. USPSTF Aspirin Therapy for Primary Prevention of CVD and CRC (April 2021) (pdf file)

    cds.ahrq.gov/sites/default/files/cds/artifact/26/Implementation%20Guide_Aspirin%20Therapy%20for%20the%20Prevention%20of%20CVD%20and%20CRC_final_2.pdf
    April 01, 2021 - Considerations for future lab value specifications include (1) international normalize ratio (INR) >

  19. CMS's Million Hearts Model Longitudinal ASCVD Risk Assessment Tool for Baseline 10-Year ASCVD Risk (pdf file)

    cds.ahrq.gov/sites/default/files/cds/artifact/71/Implementation%20Guide_CMS%20Million%20Hearts_ASCVD%20Risk%20Assessment_Level3_Sept_08.pdf
    February 01, 2018 - The additional considerations for unattended bulk operation noted above also apply to this use case. … • Review the “clinical considerations” section of this document (including the cited decision log

  20. Statin Use for the Primary Prevention of CVD in Adults: Clinician-Facing CDS Intervention (pdf file)

    cds.ahrq.gov/sites/default/files/cds/artifact/18/Implementation%20Guide_Statin%20Use%20for%20CVD%20Prevention%20in%20Adults_Clinician%20Facing%20CDS%20Intervention.pdf
    January 01, 2020 - WG members provided guidance on translation of the recommendation statement, raised considerations to … WG members provided guidance on translation of the recommendation statement, raised considerations
SHARE:
Facebook Twitter Print Facebook Share

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site:

View results from all sites